intimation for grant of options under Newgen ESOP Scheme-2022
Awaiting price reaction for this filing.
Newgen Software Technologies informed the stock exchanges that its Nomination and Remuneration Committee approved the grant of 93,300 Employee Stock Options (ESOPs) to identified employees on May 1, 2025. The options carry an exercise price of Rs. 888 per share and are governed by the Newgen ESOP Scheme-2022, which complies with SEBI's Share Based Employee Benefits rules. The options will vest over four years in tranches of 10%, 20%, 30%, and 40%, and employees have up to five years from each vesting date to exercise them. This is a routine disclosure filed under SEBI's listing regulations.
This is a standard employee incentive grant and not a new capital raise. Existing shareholders may see mild dilution over time as options vest and get exercised, but the scale (93,300 shares) is small relative to the company's overall size, so the impact on share price or shareholder value is expected to be minimal.